Your browser doesn't support javascript.
loading
A perfused multi-well bioreactor platform to assess tumor organoid response to a chemotherapeutic gradient.
Wasson, Elisa Marie; He, Wei; Ahlquist, Jesse; Hynes, William Fredrick; Triplett, Michael Gregory; Hinckley, Aubree; Karelehto, Eveliina; Gray-Sherr, Delaney Ruth; Friedman, Caleb Fisher; Robertson, Claire; Shusteff, Maxim; Warren, Robert; Coleman, Matthew A; Moya, Monica Lizet; Wheeler, Elizabeth K.
Afiliación
  • Wasson EM; Materials Engineering Division, Lawrence Livermore National Laboratory, Livermore, CA, United States.
  • He W; Biosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA, United States.
  • Ahlquist J; Materials Engineering Division, Lawrence Livermore National Laboratory, Livermore, CA, United States.
  • Hynes WF; Materials Engineering Division, Lawrence Livermore National Laboratory, Livermore, CA, United States.
  • Triplett MG; Materials Engineering Division, Lawrence Livermore National Laboratory, Livermore, CA, United States.
  • Hinckley A; Biosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA, United States.
  • Karelehto E; Department of Surgery, University of California, San Francisco, San Francisco, CA, United States.
  • Gray-Sherr DR; Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, United States.
  • Friedman CF; Department of Biomedical Engineering, Boston University, Boston, MA, United States.
  • Robertson C; Department of Computational Media, University of California Santa Cruz, Santa Cruz, CA, United States.
  • Shusteff M; Materials Engineering Division, Lawrence Livermore National Laboratory, Livermore, CA, United States.
  • Warren R; UC Davis Comprehensive Cancer Center, Davis, CA, United States.
  • Coleman MA; Materials Engineering Division, Lawrence Livermore National Laboratory, Livermore, CA, United States.
  • Moya ML; Department of Surgery, University of California, San Francisco, San Francisco, CA, United States.
  • Wheeler EK; Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, United States.
Front Bioeng Biotechnol ; 11: 1193430, 2023.
Article en En | MEDLINE | ID: mdl-37324446
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Bioeng Biotechnol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Bioeng Biotechnol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos